Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

REGENERON PHARMACEUTICALS, INC.

(REGN)
  Report
Delayed Nasdaq  -  04:00:01 2023-03-24 pm EDT
820.00 USD   +2.22%
09:26aIs Deutsche Bank the next one?
MS
09:01aBarclays Adjusts Price Target on Regeneron Pharmaceuticals to $915 From $815, Keeps Overweight Rating
MT
08:49aBMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $1,040 From $1,025, Maintains Outperform Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about REGENERON PHARMACEUTICALS, INC.
09:01aBarclays Adjusts Price Target on Regeneron Pharmaceuticals to $915 From $815, Keeps Ove..
MT
08:49aBMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $1,040 From $1,025, Ma..
MT
08:08aWells Fargo Adjusts Regeneron Pharmaceuticals Price Target to $915 From $860, Maintains..
MT
08:01aBaird Adjusts Regeneron Pharmaceuticals Price Target to $800 From $756, Maintains Neutr..
MT
07:59aJefferies Upgrades Regeneron Pharmaceuticals to Buy From Hold, Adjusts Price Target to ..
MT
03/23Gain in New-Home Sales Helps Equities Rise
MT
03/23RBC Raises Regeneron Pharmaceuticals' Price Target to $833 From $802, Maintains Sector ..
MT
03/23Piper Sandler Raises Regeneron Pharmaceuticals' Price Target to $850 From $800, Maintai..
MT
03/23Baird Raises Regeneron Pharmaceuticals' Price Target to $800 From $756, Maintains Neutr..
MT
03/23Raymond James Upgrades Regeneron Pharmaceuticals to Market Perform From Underperform
MT
03/23Regeneron Pharmaceuticals, Sanofi Shares Rise on Trial Results of Respiratory Disease T..
MT
03/23Regeneron Pharmaceuticals Up Nearly 7%, on Track for Record High Close -- Data Talk
DJ
03/23Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
MT
03/23Sector Update: Health Care
MT
03/23EF Hutton Adjusts Regeneron Pharmaceuticals Price Target to $862 From $853, Maintains B..
MT
More most relevant news
All news about REGENERON PHARMACEUTICALS, INC.
09:26aIs Deutsche Bank the next one?
MS
09:01aBarclays Adjusts Price Target on Regeneron Pharmaceuticals to $915 From $815, Keeps Ove..
MT
08:49aBMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $1,040 From $1,025, Ma..
MT
08:08aWells Fargo Adjusts Regeneron Pharmaceuticals Price Target to $915 From $860, Maintains..
MT
08:01aBaird Adjusts Regeneron Pharmaceuticals Price Target to $800 From $756, Maintains Neutr..
MT
07:59aJefferies Upgrades Regeneron Pharmaceuticals to Buy From Hold, Adjusts Price Target to ..
MT
06:23aAnalyst recommendations: Coinbase, Eastman Chemical, KB Home, Re..
MS
03/23ADRs End Mostly Higher, Tencent and Sanofi Trade Actively
DJ
03/23New-Home Sales Data Help Lift Equities
MT
03/23Gain in New-Home Sales Helps Equities Rise
MT
More news
News in other languages on REGENERON PHARMACEUTICALS, INC.
10:25aCompañías que se deben tener muy en cuenta por técnico este viernes en Wall Street
06:30aUSA-Les valeurs à suivre à Wall Street (actualisé)
03/23Les données sur les ventes de logements neufs soutiennent les actions
03/23La hausse des ventes de logements neufs favorise la progression des actions
03/23Point marchés-Clôture mitigée pour les actions européennes avec les banques centrales
03/23MÄRKTE EUROPA/Wenig verändert nach Fed - Sanofi gesucht mit Dupixent
03/23Les actions de Regeneron Pharmaceuticals et de Sanofi augmentent à la suite des résulta..
03/23MÄRKTE EUROPA/Börsen holen Verluste auf - Sanofi ziehen deutlich an
03/23Wall Street monte avec l'espoir d'une pause dans les hausses de taux États-Unis
03/23Wall Street monte avec l'espoir d'une pause dans les hausses de taux US
More news
Analyst Recommendations on REGENERON PHARMACEUTICALS, INC.
09:01aBarclays Adjusts Price Target on Regeneron Pharmaceuticals to $915 From $815, Keeps Ove..
MT
08:49aBMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $1,040 From $1,025, Ma..
MT
08:08aWells Fargo Adjusts Regeneron Pharmaceuticals Price Target to $915 From $860, Maintains..
MT
08:01aBaird Adjusts Regeneron Pharmaceuticals Price Target to $800 From $756, Maintains Neutr..
MT
07:59aJefferies Upgrades Regeneron Pharmaceuticals to Buy From Hold, Adjusts Price Target to ..
MT
More recommendations
Press releases
03/23Dupixent« (dupilumab) Demonstrates Potential to Become First Biologic to Treat COPD by ..
GL
03/23Dupixent« (dupilumab) Demonstrates Potential to Become First Biologic to Treat COPD by ..
AQ
03/22FDA Approves First-in-class Evkeeza« (evinacumab-dgnb) for Young Children with Ultra-ra..
GL
03/22FDA Approves First-in-class Evkeeza« (evinacumab-dgnb) for Young Children with Ultra-ra..
AQ
03/21Dupixent« (dupilumab) Approved by European Commission as First and Only Targeted Medici..
GL
More press releases
Upcoming event on REGENERON PHARMACEUTICALS, INC.
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer